1-8 of 8
Haili Lang
Close
Sort by
Journal Articles

Phase I Study to Improve Anti-Viral Immunity after Cord Blood Transplantation Using Cord-Blood-Derived Multi-Virus-Specific T-Cells

Shweta Bansil, Cecilia Motta, Rachel Dicioccio, Samuel O'Brien, Haili Lang, Michael Keller, Allistair Abraham, David Jacobsohn, Blachy J Davila Saldana, Amanda L. Olson, Elizabeth J Shpall, Indreshpal Kaur, Patrick J Hanley, Catherine M Bollard
Journal: Blood
Blood (2022) 140 (Supplement 1): 10239–10240.
https://doi.org/10.1182/blood-2022-167874
Published: 2022
Journal Articles

Phase I Study Evaluating Outcomes of Autologous HIV-Specific T Cells Targeting Non-Escaped Epitopes (HST-NEET) Therapy in HIV+ Individuals on ART (NCT03485963)

Danielle K. Sohai, Michael Keller, Patrick J. Hanley, Anushree Datar, Emily Reynolds, Dennis Copertino, Chase McCann, Haili Lang, Cecilia Motta, Andrew Wilson, Rebecca Lynch, Winiffer Conce Alberto, Zabrina L. Brumme, Natalie N. Kinloch, Conrad Russell Y. Cruz, Lynsay MacLaren Ehui, Sarah Henn, R. Brad Jones, Catherine M Bollard
Journal: Blood
Blood (2022) 140 (Supplement 1): 7498–7499.
https://doi.org/10.1182/blood-2022-165775
Published: 2022
Journal Articles

Percent Patient NK and T Cells at Day 28 Predict Graft Outcome after Haploidentical Hematopoietic Cell Transplant for Sickle Cell Disease

Mariah Jensen-Wachspress, Haili Lang, Gelina Sani, Deepali K Bhat, Emily Limerick, Xin Xu, Kenneth Fulton, Catherine M Bollard, Courtney D. Fitzhugh, Allistair Abraham
Journal: Blood
Blood (2022) 140 (Supplement 1): 7609–7610.
https://doi.org/10.1182/blood-2022-166878
Published: 2022
Journal Articles

Outcome of Donor-Derived Tumor Associated Antigen-Specific T Cell Therapy in Patients with High-Risk or Relapsed Acute Leukemia Post Allogeneic BMT

Hannah Kinoshita, Kenneth R. Cooke, Melanie Grant, Maja Stanojevic, Conrad Russell Young Cruz, Michael Keller, Maria Fernanda Fortiz, Fahmida Hoq, Haili Lang, John Barrett, Hua Liang, Jay Tanna, Nan Zhang, Abeer Shibli, Anushree Datar, Kirsten M. Williams, Hema Dave, Jeffrey Dome, David Jacobsohn, Patrick Hanley, Richard J. Jones, Catherine M. Bollard
Journal: Blood
Blood (2021) 138 (Supplement 1): 2828.
https://doi.org/10.1182/blood-2021-153207
Published: 2021
Journal Articles

SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein

Michael D. Keller, Katherine M. Harris, Mariah A. Jensen-Wachspress, Vaishnavi V. Kankate, Haili Lang, Christopher A. Lazarski, Jessica Durkee-Shock, Ping-Hsien Lee, Kajal Chaudhry, Kathleen Webber, Anushree Datar, Madeline Terpilowski, Emily K. Reynolds, Eva M. Stevenson, Stephanie Val, Zoe Shancer, Nan Zhang, Robert Ulrey, Uduak Ekanem, Maja Stanojevic, Ashley Geiger, Hua Liang, Fahmida Hoq, Allistair A. Abraham, Patrick J. Hanley, C. Russell Cruz, Kathleen Ferrer, Lesia Dropulic, Krista Gangler, Peter D. Burbelo, R. Brad Jones, Jeffrey I. Cohen, Catherine M. Bollard
Journal: Blood
Blood (2020) 136 (25): 2905–2917.
https://doi.org/10.1182/blood.2020008488
Published: 2020
Includes: Supplemental data
Journal Articles

Human Papillomavirus (HPV)--Specific T-Cells Can be Generated from Unimmunized Donors for Third Party Cell Therapy of HPV-Associated Neoplasms

Conrad Russell Young Cruz, MD PhD, Sarah McCormack, BA, Kaylor Elizabeth Wright, BS, Allison B Powell, BS, Haili Lang, MS, Cecilia Barese, MDPhD, Connie Trimble, MD, Michael Keller, MD, Ephraim J. Fuchs, MD MBA, Catherine M. Bollard, MD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 1923.
https://doi.org/10.1182/blood.V130.Suppl_1.1923.1923
Published: 2017
Journal Articles

Clinical Use of CMV-Specific T Cells Derived from CMV-Naïve Donors

Patrick Hanley, PhD, Michael Keller, MD, Lauren Roesch, Devin Saunders, Haili Lang, Blachy Davila, MD, Ulrich A. Duffner, MD, Divyesh Kukadiya, Fahmida Hoq, MD, Catherine M. Bollard, MD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 4470.
https://doi.org/10.1182/blood.V130.Suppl_1.4470.4470
Published: 2017
Journal Articles

Complete Remissions Post Infusion of Multiple Tumor Antigen Specific T Cells for the Treatment of High Risk Leukemia and Lymphoma Patients after HCT

Kirsten M. Williams, MD, Patrick Hanley, PhD, Melanie Grant, PhD, Maria Fernanda Fortiz, BA, Maja Stanojevic, MD, Mimi Ismail, BA, Fahmida Hoq, MD, Maria Martin Manso, PhD, Jamie Hoover, Robert Ulrey, BA, Ella Kathy Mintz, MS, Anna Namata, BS, Elizabeth Williams, Shuroug Albihani, Michael Keller, MD, Conrad Russell Young Cruz, MD PhD, Haili Lang, Austin John Barrett, MD FRCP, FRCPath, Stephen Gottschalk, MD, Hao Liu, Shannon R. McCurdy, MD, Richard J. Jones, MD, Catherine M. Bollard, MD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 4516.
https://doi.org/10.1182/blood.V130.Suppl_1.4516.4516
Published: 2017